Structured Summary
Abstract
A humanized monoclonal antibody that binds specifically to TNF-ALPHA and blocks its interaction with endogenous TNF RECEPTORS to modulate INFLAMMATION. It is used in the treatment of RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS; CROHN'S DISEASE and ULCERATIVE COLITIS.
MeSH Record
Classification
Broader headings
Related Concepts
Knowledge Graph
Drag nodes to rearrange; hover to trace links; click a node to open its page.
Drug Class
Pharmacological Action
MeSH Record
See Also
MeSH Record
Synonyms
7 entry terms
- Adalimumab-adbm
- Adalimumab-atto
- Amjevita
- Cyltezo
- D2E7 Antibody
- Humira
- Antibody, D2E7
MeSH Record
Aspects Covered
24 allowable subheadings
Indexed with the subheadings administration & dosage, adverse effects, analysis, biosynthesis, blood, cerebrospinal fluid, chemistry, classification, drug effects, economics, genetics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, physiology, poisoning, radiation effects, therapeutic use, toxicity, ultrastructure, urine.
MeSH Record
History Note
2016 (2002)
MeSH Hierarchy
Tree Numbers
AMA Style
References
- National Library of Medicine. Adalimumab. Medical Subject Headings (MeSH). 2026. Unique ID D000068879. http://id.nlm.nih.gov/mesh/2026/D000068879
- Adalimumab. In: Wikipedia. https://en.wikipedia.org/wiki/Adalimumab
- Adalimumab. In: Wikidata. https://www.wikidata.org/wiki/Q348260